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Most cases of excessive hair loss and
unwanted hair growth (e.g., effluvium,
alopecia, hirsutism, hypertrichosis)
result in part from major disturbances
in the cyclic transformation of hair fol-
licles (HFs), namely in their switch from
active growth and pigmented hair shaft
production (anagen) to apoptosis-
driven HF involution (catagen) (Oh
et al., 2016; Paus and Cotsarelis,
1999). It is now clear that this switch
is profoundly influenced by complex
neuroendocrine pathways, which still
await systematic therapeutic targeting
(Paus et al., 2014).
In this context, the endocannabinoid
system is of special interest
(Maccarrone et al., 2015; Ola´h and
Bı´ro´, 2017; To´th et al., 2019). Specif-
ically, activation of CB1 receptors by
the endocannabinoid anandamide, and
the plant-derived (e)-D9-trans-tetrahy-
drocannabinol, promotes premature
catagen entry in human scalp HFs
ex vivo (Telek et al., 2007). However, 2-
arachidonoylglycerol, another proto-
typic endocannabinoid, does not
modulate HF growth ex vivo, suggest-
ing functional heterogeneity between
different cannabinoids in terms of hu-
man hair growth modulation (Telek
et al., 2007).
This motivated us to also explore
how another phytocannabinoid,
(e)-cannabidiol (CBD), impacts on
human hair growth. This major non-
psychotropic phytocannabinoid does
not activate CB1 receptors, but may
context-dependently signal via modu-
lating several other targets (e.g.,
GPR55, 5-HT1a, or m-opioid receptors)Abbreviations: CBD, (e)-cannabidiol; HF, hair follicle
potential vanilloid-4
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Journal of Investigative Dermatology (2020), Volum(Pertwee, 2008). Moreover, it is used
in clinical practice in multiple scle-
rosis and certain epilepsies, and is
currently under intense investigation
for various uses in clinical medicine,
ranging from neuropsychiatric disor-
ders to acne (ID at ClinicalTrials.gov:
NCT03573518) (Armstrong et al.,
2015; Chelliah et al., 2018; Crippa
et al., 2018; Esposito et al., 2013;
Pisanti et al., 2017). In fact, CBD ex-
erts complex sebostatic and anti-
inflammatory effects on the piloseba-
ceous unit by activating both transient
receptor potential vanilloid-4 (TRPV4)
ion channels and adenosine A2A re-
ceptors on sebocytes (Ola´h et al.,
2014). Topically administered CBD is
likely to also reach human HFs, which
express functional TRPV4 receptors,
the stimulation of which induces pre-
mature catagen (Szabo´ et al., 2019),
whereas adenosine reportedly pro-
motes human hair growth (Oura et al.,
2008).
Therefore, we asked in the current
exploratory pilot study whether and
how CBD impacts on microdissected,
organ-cultured human scalp HFs
(Langan et al., 2015) and primary hu-
man outer root sheath keratinocytes
(ORSKs) isolated and cultured from
plucked hair shafts (Ramot et al., 2018),
obtained after written informed consent
from dermatologically healthy in-
dividuals. The study adhered to
Helsinki guidelines, and was institu-
tionally and governmentally approved.
For methodological details, see
Supplementary Materials and Methods.
First, we probed if CBD influenced
hair shaft production of microdissected; TLR, toll-like receptor; TRPV4, transient receptor
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e 140human HFs. We found that, when
applied at 0.1 mM, CBD tended to pro-
mote hair shaft elongation, but, unex-
pectedly, did not modulate HF cycling
and hair matrix keratinocyte prolifera-
tion or apoptosis ex vivo (Figure 1). This
tendency may represent a pseudo-
elongation of the hair shaft, which is
pushed out of its anchorage in the HF by
tissue shrinkage during the course of
organ culture. However, 10 mM CBD
significantly suppressed hair shaft pro-
duction (Figure 1a and Supplementary
Figure S1), and induced development
of catagen morphology (Figure 1b and
c). This was accompanied by a signifi-
cant reduction of the ratio of prolifer-
ating (Ki-67þ), and a significant increase
in the percentage of apoptotic (TUNELþ)
hair matrix keratinocytes (Figure 1d
and e), indicating the onset of an
apoptosis-associated involution. This
invited the hypothesis that CBD
may concentration-dependently target
different receptors.
This hypothesis was probed in
cultured ORSKs, which facilitate
mechanistic analyses and permit higher
throughput assessments than very
scarcely available scalp HFs. In line
with the above HF data, CBD rapidly
decreased the ORSK count (3- to 72-
hour treatments; CyQUANT assay;
Supplementary Figure S2a-d), reduced
viability, and induced chiefly apoptotic
cell death in a concentration- and time-
dependent manner (24-hour treat-
ments; MTT assay and combined
1,10,3,3,30,30-hexamethylindodicarbo-
cyanine iodide (DilC1(5))-SYTOX Green
labeling; Supplementary Figure S3a
and b).
CBD activates the mostly calcium-
permeable TRPV4 ion channels (Ola´h
et al., 2014), the stimulation of which
promotes catagen in human HFs
ex vivo (Szabo´ et al., 2019). In line with
this, the catagen-promoting CBD
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Figure 1. CBD differentially influences elongation as well as hair cycle of human microdissected HFs. (a) Hair shaft elongation curves. HFs (N ¼ 54 HFs
from three donors per treatment, expressed as mean  standard error of the mean) were treated as indicated. ***P < 0.001, respectively, significant differences
as indicated at day 7 (i.e., after 6 days of treatment). (b) Results of microscopic hair cycle staging. ***P < 0.001 significant differences (chi-square test followed
by Fisher’s exact test) compared with the control group. (c) Sections of representative HFs following hematoxylin and eosin staining. (d) Percentages of
proliferating (Ki-67þ) and apoptotic (TUNELþ) matrix keratinocytes were determined. Data are expressed as mean  standard error of the mean of N ¼ 36e40
HFs from three donors per treatment. *P< 0.05, **P< 0.01, and ***P < 0.001, respectively, significant differences compared with the respective control groups.
(e) Representative pictures of Ki-67 (red) and TUNEL (green) double staining after the indicated treatments. Nuclei were counterstained by DAPI (blue). CBD,
(e)-cannabidiol; HF, hair follicle. Bar ¼ 50 mm.
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cium influx in cultured ORSKs
(Figure 2a and b), which was almost
completely abrogated by the highly
selective TRPV4 antagonist, HC067047
(1 mM) (Everaerts et al., 2010; Figure 2c
and d). This suggests that, at micro-
molar concentrations, CBD activatesTRPV4 in human ORSKs, and that its
catagen-promoting effect on organ-
cultured HFs may be stimulated via
signaling through this newly identified
catagen-inducing pathway.
Reportedly, toll-like receptor 3 acti-
vation on human ORSKs leads to
inflammasome activation andsubsequent IL-1b production (Shin et al.,
2017), which may create a proin-
flammatory, catagen- and HF dystrophy-
promoting signaling milieu (Hoffmann
et al.,1998; Philpott et al., 1996;
Ru¨ckert et al., 2000). Since CBD exerts
remarkable anti-inflammatory effects in
several systems (Esposito et al., 2013;www.jidonline.org 485
0 50
1.0
1.1
1.2
1.3
100 150 200
Elapsed time (s)
N
or
m
al
iz
ed
 R
el
at
ive
Fl
uo
re
sc
en
ce
 (F
/F 0
)
250 300
ctrl
10 μM CBD
1 μM CBD
50 μM CBD
5 μM CBD
100 μM CBD
a
1.0
0
(ctrl)
N
or
m
al
iz
ed
 R
el
at
ive
 
Fl
uo
re
sc
en
ce
 (F
/F 0
)
1.1
1.2
*
**
**1.3
1 5
CBD concentration (μM)
10 50 100
b
0 50
1.0
1.25
1.5
100 150 200
Elapsed time (s)
N
or
m
al
iz
ed
 R
el
at
ive
 
Fl
uo
re
sc
en
ce
 (F
/F 0
)
250 300
50 μM CBD + 1 μM HC067047
50 μM CBD
control
c
0CBD (μM):
HC067047 (μM):
1.0
1.1Pe
ak
 re
la
tiv
e 
flu
or
es
ce
nc
e
(F
/F 0
)
1.2
1.3
1.4
1.5
1.6
***
***
50 50
0 0 1
***
d
IL-1β
0
200
400
**
***
***
##
$$$
600
800
1000
IL-6
**
***
***
##
$$$
αTNF-
*
**
*
###
$
IL-8
N.S.
*
***
***
### ##
Control
Poly-(I:C)
Poly-(I:C)+CBD
Poly-(I:C)+CBD+CGS 15493
e
Ex
pr
es
sio
n 
of
 p
ro
-in
fla
m
m
at
or
y 
m
ed
ia
to
rs
(ve
hic
le 
co
ntr
ol=
10
0%
)
Figure 2. Procatagen concentrations of CBD activate TRPV4 ion channels, whereas at submicromolar concentration it exerts anti-inflammatory actions via
the activation of adenosine receptors. (aed) Fluo-4 AMebased fluorescent calcium measurements and their statistical analyses. Compounds were applied as
indicated by the respective arrows. (a, c) Fluorescence (measured in relative fluorescence units) was normalized to the baseline, and is presented as mean 
standard error of the mean of F/F0 values of N ¼ 3e6 wells. (b, d) Mean  standard error of the mean of the peak F/F0 values measured after the indicated
treatments. *P < 0.05, **P < 0.01, or ***P < 0.001, respectively, significant differences compared with (b) the control or (d) as indicated. (e) Quantitative
real-time PCR. TNF-a, IL-1b, IL-6, and IL-8 mRNA expression in human ORSKs was determined following the indicated 3-hour treatments (Poly-(I:C), 20 mg/ml;
CBD, 0.1 mM; CGS 15943, 0.1 mM). Data are presented by using DDCT regarding glyceraldehyde 3-phosphate dehydrogenaseenormalized mRNA
expressions of the vehicle control as 1. Data are expressed as mean  standard deviation of three determinations. Two additional experiments yielded
similar results. */$P < 0.05, **/##P < 0.01, or ***/###/$$$P < 0.001, respectively (*vs. control; #vs. Poly-(I:C); $vs. Poly-(I:C) þ CBD). CBD, (e)-cannabidiol;
CGS 15943, a pan-antagonist of the adenosine receptors; F/F0, normalized relative fluorescence; HC067047, specific TRPV4 antagonist; N.S., not significant;
ORSK, outer root sheath keratinocyte; Poly(I:C), polyinosinic-polycytidylic acid (toll-like receptor 3 activator); TNF-a, tumor necrosis factor-a.
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SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online
version of the paper at www.jidonline.org, and at
https://doi.org/10.1016/j.jid.2019.07.690.
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a noncytotoxic (Supplementary
Figures S2a-d and S3a and b) and
noncatagen-promoting (Figure 1a-e)
CBD concentration (i.e., 0.1 mM) im-
pacts on the production of catagen-
promoting cytokines by ORSKs. Inter-
estingly, CBD effectively antagonized not
only the toll-like receptor 3-activator
polyinosinic-polycytidylic acid-induced
upregulation of IL-1b, but also that of
IL-6, IL-8, and tumor necrosis factor-a
(Figure 2e). Similar to sebocytes, these
anti-inflammatory actions of CBD
appear to primarily depend on adeno-
sine receptor-mediated signaling,
because the adenosine receptor pan-
antagonist CGS 15943 (Ghai et al.,
1987; Klotz, 2000; Williams et al.,
1987) almost completely abrogated the
CBD effects reported above (Figure 2e).
Besides potentially reducing the hair
growth-inhibitory effects of the likely
high level of these wounding-associated
cytokines of freshly microdissected
HFs compared with vehicle-treated
controls, the moderate hair shaft-
stimulatory effects of 0.1 mM CBD
(Figure 1a) may also result from
increased fibroblast growth factor-7
transcription by human dermal papilla
fibroblasts (Iino et al., 2007). Therefore,
whether submicromolar CBD helps to
normalize a catagen-promoting proin-
flammatory HF signaling milieu, re-
duces the cytokine-driven recruitment
and activation of hair growth inhibitory
immune cells, and promotes the pro-
duction of hair growth-supporting
growth factors such as fibroblast
growth factor-7 deserves further
investigation.
Although our pilot data need to be
followed up by systematic dose-
response experiments in a wider range
of CBD concentrations, tested in
HF organ cultures from additional
patients, the current data invite the
hypothesis that submicromolar, adeno-
sine receptor-activating doses of CBD
may reduce the intrafollicular produc-
tion of catagen-promoting cytokines
and could thus become useful as
adjunct therapy for inflammatory hair
loss disorders characterized by exces-
sive levels of these cytokines. Instead,
TRPV4-activating micromolar concen-
trations of CBD are attractive candidate
inhibitors of unwanted hair growth
(Supplementary Figure S4). If thecurrent ex vivo findings, which imitate
a systemic mode of CBD application,
are reproducible after topical applica-
tion, and if administering sub-
micromolar versus micromolar topical
CBD can indeed evoke differential,
therapeutically desired effects in clin-
ical hair growth management, these
results deserve rigorous exploration.
Detailed discussion about the limita-
tions of this study can be found in
Supplementary Discussion.
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Pemphigus foliaceus (PF) is an autoim-
mune disease, sporadic across the
globe, but endemic in Brazil. A signifi-
cant portion of PF autoantibodies target
desmosomal glycoproteins, especially
desmoglein-1, which are associated
with the occurrence of painful blisters in
the granular skin layer (Spindler et al.,
2007). Epigenetic mechanisms have
been implicated in autoimmune skin
diseases. Among them, dysregulated
DNA and histone methylation
contribute to systemic lupus erythema-
tosus (Hung et al., 2018), psoriasis
(Manczinger and Keme´ny, 2013),
pemphigus vulgaris (Zhao et al., 2012a),
and alopecia areata (Zhao et al., 2012b).
To investigate the association of genetic
polymorphisms in the alteration of these
mechanisms in PF, we compared 229
patients to 194 controls (52% women,
median age of 43 years old, unrelated,predominantly euro-descendent, and
from rural areas), genotyped with
microarray hybridization (CoreExome-
24, version 1.1, Illumina, San Diego,
CA). The Brazilian National Ethics in
Research Commission approved the
protocol (02727412.4.0000.0096), and
all participants gave written informed
consent, according to the Declaration of
Helsinki. From 1984 to 2015, in-
dividuals were recruited in the South
and/or Central-Western regions of
Brazil, in the Hospital Adventista do
Peˆnfigo (Campo Grande), Lar de Car-
idade (Uberaba), Hospital de Clı´nicas
(Ribeira˜o Preto), and Hospital de Clı´ni-
cas (Curitiba). All patients presented
positive Nikolsky signal and sun-
exposed lesions (155 localized and 74
generalized); a total of 41 presented
active lesions at the moment of blood
collection, 87% of the patients were
anti-desmoglein-1 positive, and allpatients were negative for anti-
neutrophil-cytoplasmic, anti-mitochon-
drial, anti-liver-kidney-microsomal, and
anti-gastric-parietal-cells by ELISA
(Oliveira et al., 2016) or indirect
immunofluorescence (Nisihara et al.,
2003). A small percentage of patients
and controls (0.8e2%) were low-
positive and asymptomatic for anti-
smooth-muscle, anti-thyroid-micro-
some, and anti-nuclear-antibodies
(Nisihara et al., 2003).
We selected 1,793 variants in 63
genes that code for lysine methyl-
transferases (KMT), demethylases (KDM),
DNA methyltransferases, and ten-
eleven translocation demethylases. We
excluded rare variants (minor allele fre-
quencies <0.01), variants that deviated
from Hardy-Weinberg equilibrium in
controls (P < 0.05), and variants in link-
age disequilibrium (r2  0.8). A total of
566 polymorphisms remained and were
analyzed using logistic regression with
correction for two principal components
using PLINK, version 1.1.9 (http://zzz.
bwh.harvard.edu/plink/). Haplotypes
were reconstructed for all 61 single
SUPPLEMENTARY MATERIALS AND
METHODS
Materials
(e)-Cannabidiol (CBD), the TRPV4-
selective antagonist HC067047
(Armstrong et al., 2015; http://www.
guidetopharmacology.org/GRAC/Ligand
DisplayForward?tab¼biology&ligandId¼
4213), and the adenosine
receptor pan-antagonist CGS 15943
(Ghai et al., 1987; Klotz, 2000; http://
www.guidetopharmacology.org/GRAC/
LigandDisplayForward?ligandId¼384)
were purchased from Tocris (Bristol,
United Kingdom), whereas the toll-like
receptor 3 activator double-stranded
RNA polyinosinic-polycytidylic acid
was obtained from Sigma-Aldrich (St
Louis, MO). CBD was dissolved in ab-
solute ethanol, whereas the solvent of
HC067047 and CGS 15943 was
DMSO. Polyinosinic-polycytidylic acid
was dissolved in filtered distilled water.
Control cultures were always treated
with appropriate amount of vehicle(s).
Isolation and maintenance of hair
folicles
Human skin samples were obtained
following obtaining written informed
consent from healthy individuals un-
dergoing dermatosurgery. The study
adhered to Helsinki guidelines, and
was institutionally and governmentally
approved by the Institutional Research
Ethics Committee and the Government
Office for Hajdu´-Bihar County
(protocol no.: DE OEC RKEB/IKEB
3724-2012; document IDs: IX-R-052/
01396-2/2012, IF-12817/2015, IF-
1647/2016, and IF-778-5/2017). Hu-
man anagen VI hair follicles (HFs) were
isolated from skin obtained from two
male (28 and 32 years old) and one
female (58 years old) patients under-
going neurosurgical intervention as
described previously (Borbı´ro´ et al.,
2011; Langan et al., 2015; Ola´h et al.,
2016). Isolated HFs were cultured in
William’s E Medium (Invitrogen,
Paisley, United Kingdom) supple-
mented with 2 mM L-glutamine (Invi-
trogen), 10 ng/ml hydrocortisone, 10
mg/ml insulin, and antibiotics (all from
Sigma-Aldrich). Treatments were initi-
ated 24 hours after the isolation.
Medium was changed every other day,
whereas treatment with CBD (or
vehicle) was performed daily. Length
measurements were performed on
individual HFs using a light microscope
with an eyepiece measuring graticule.
Isolation and culture of outer root
sheath keratinocytes
Isolation and culture of outer root
sheath keratinocytes (ORSKs) was per-
formed following our previously opti-
mized protocols (see, e.g., Borbı´ro´
et al., 2011; Ramot et al., 2018). In
brief, plucked hair shafts of healthy
volunteers (both females and males;
aged 23e47 years old) were digested
using trypsin to isolate ORSKs. Isolated
ORSKs were seeded to a feeder layer of
primary human dermal fibroblasts that
were pretreated overnight with mito-
mycin C (0.4 mg/ml from Sigma-
Aldrich) to block their proliferation.
Human dermal fibroblasts were ob-
tained from de-epidermized dermis
using enzymatic digestion. Cocultures
of nonproliferating feeder human
dermal fibroblasts and ORSKs were
maintained in a 1:3 mixture of Ham’s F-
12 and DMEM (both from Invitrogen)
supplemented with 0.1 nM cholera
toxin, 5 mg/ml insulin, 0.4 mg/ml hy-
drocortisone, 2.43 mg/ml adenine, 2
nM triiodothyronine, 10 ng/ml EGF, 1
mM ascorbyl-2-phosphate, and antibi-
otics (all from Sigma-Aldrich). ORSKs
were plated for subsequent experiments
on collagen-coated (1%; 37 C for 1
hour; obtained from Sigma-Aldrich)
culture dishes without human dermal
fibroblast feeder layer.
Hematoxylin and eosin staining of
frozen tissue sections
Cryosections of 6 mm thickness of the
HFs were dried at room temperature
(10 minutes), and fixed in precooled
acetone (10 minutes at 20 C). Sec-
tions were then washed in distilled
water for 1 minute at room tempera-
ture, and stained with Mayer’s hema-
toxylin for 35 seconds at room
temperature. Following gentle washing
under the tap water for 15 minutes at
room temperature, sections were
stained with 0.1% Eosin Y solution (1
minute at room temperature). Sections
were then dehydrated (washing three to
four times in 70%, 96%, and 100%
ethanol), and incubated in xylene (2 
10 minutes at room temperature).
Finally, sections were mounted by us-
ing Eukitt quick-hardening mounting
medium (Sigma-Aldrich). Images were
taken by using bright-field function of a
Nikon Eclipse E600 microscope
(Nikon, Tokyo, Japan). Hematoxylin
and eosin staining was then used for
studying HF morphology, and, together
with Ki-67/TUNEL double labeling , for
staging hair cycle to anagen, early
catagen, and late catagen according to
predefined objective morphological
criteria (Kloepper et al., 2010).
Assessment of proliferation and
apoptosis of matrix keratinocytes
(Ki-67/TUNEL double labeling)
Proliferation and apoptosis were
assessed by Ki-67/TUNEL double im-
munostaining as described previously
(Borbı´ro´ et al., 2011; Kloepper et al.,
2010; Ola´h et al., 2016). In brief, cry-
osections (6 mm) were air dried for 10
minutes at room temperature, and then
fixed for 10 minutes in 1% para-
formaldehyde in phosphate-buffered
saline (PBS) (15 mM NaCl, 20 mM
Na2HPO4 [pH 7.4]; all from Sigma-
Aldrich) at room temperature. Samples
were rehydrated in PBS for 5 minutes
(2), and were then postfixed for 5
minutes in precooled ethanoleacetic
acid 2:1 at 20 C, and then rehy-
drated in PBS again for 5 minutes (3).
After rehydration, sections were incu-
bated with an equilibration buffer for 5
minutes at room temperature, and then
incubated with TdT enzyme for 1 hour
at 37 C. To reveal proliferation, mouse
anti-human Ki-67 (DAKO, Carpinteria,
CA) primary antibody was used. In
addition, to assess apoptosis, a TUNEL
assay was performed using an ApopTag
Fluorescein In Situ Apoptosis Detection
Kit (Merck Millipore) following the
manufacturer’s instructions. Sections
were incubated with the primary anti-
body overnight at 4 C, and then with
the secondary antibody (Alexa Fluor
568 Goat anti-Mouse IgG; Invitrogen)
for 45 minutes at room temperature.
Sections were washed in PBS and were
counterstained with DAPI (Sigma-
Aldrich) and mounted with
Fluoromont-G (Southern Biotechnology
Associates, Birmingham, AL). Visuali-
zation of the signals was performed
using a Nikon Eclipse E600 fluorescent
microscope (Nikon). The ratio of
proliferating (Ki-67þ) and apoptotic
(TUNELþ) cells was determined in
defined reference regions of the hair
bulb, and are expressed as the
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percentage of the total cell count
determined by counting DAPIþ nuclei.
Quantitative real-time PCR
Quantitative real-time PCR was per-
formed on a Stratagene MXP3005p
detection system (Agilent Technologies,
Santa Clara, CA) using the 5ʹ nuclease
assay, as we have described previously
(Ola´h et al., 2014). In brief, ORSKs
were seeded to Petri dishes (d ¼ 35
mm; 500,000 cells/1.5 ml medium/
dish), and were harvested following the
indicated 3-hour treatments. Total RNA
was then isolated using TRIzol reagent
(Invitrogen) according to the manufac-
turer’s protocol. The concentrations and
purities of the RNA samples were
measured using a NanoDrop ND-1000
spectrophotometer (Thermo Fischer
Scientific, Budapest, Hungary), and
samples were kept at 20 C until
further processing. Next, DNase treat-
ment was performed according to the
manufacturer’s protocol, and, then, 3
mg of total RNAwas reverse-transcribed
into cDNA using a High-Capacity
cDNA Kit from Life Technologies
Hungary, Budapest, Hungary. PCR
amplification was performed using
the TaqMan Gene Expression
Assays (assay IDs: Hs00174097_m1 for
IL-1a; Hs00985639_m1 for IL-6;
Hs00174103_m1 for IL-8; and
Hs00174128_m1 for tumor necrosis
factor-a) and the TaqMan Universal
PCR Master Mix protocol (Applied
Biosystem, Waltham, MA). As internal
control, transcripts of glyceraldehyde 3-
phosphate dehydrogenase (assay ID:
Hs99999905_m1) were determined.
The amount of the transcripts was
normalized to those of the house-
keeping gene using the DCT method,
and then the relative expression values
were further normalized those of the
vehicle-treated control (DDCT method).
Fluorescent Calcium measurements
ORSKs were seeded in 96-well black
well plates with clear bottom (Greiner
Bio-One, Kremsmuenster, Austria) pre-
viously coated with 1% collagen in
ORSK medium at a density of 20,000
cells per well, and incubated at 37 C
for 24 hours. The cells were washed
once with 10 mg/ml BSA and 2.5 mM
probenecid (both from Sigma-Aldrich)
containing Hank’s solution (136.8 mM
NaCl, 5.4 mM KCl, 0.34 mM
Na2HPO4, 0.44 mM KH2PO4, 0.81
mM MgSO4, 1.26 mM CaCl2, 5.56 mM
glucose, 4.17 mM NaHCO3 [pH 7.2],
all from Sigma-Aldrich), and then were
loaded with 1 mM Fluo-4 AM (Life
Technologies Hungary ) dissolved in
Hank’s solution (100 ml/well) at 37 C
for 30 minutes. The cells were then
washed three times with Hank’s solu-
tion (100 ml/well). The plates were then
placed into a FlexStation II384 Multi-
Mode Microplate Reader (Molecular
Devices, Sunnyvale, CA) and alter-
ations of the cytoplasmic calcium con-
centration (reflected by changes in
fluorescence; lEX ¼ 490 nm, lEM ¼
520nm) were monitored at room tem-
perature following the application of
the indicated substances or vehicle. To
probe reactivity and viability of the
cells, at the end of each measurement,
0.2 mg/ml adenosine triphosphate was
administered as a positive control (data
not shown). Data are presented as F/F0,
where F0 is the average baseline fluo-
rescence (i.e., before compound appli-
cation), whereas F is the actual
fluorescence.
Determination of cellular
proliferation
The degree of cellular growth (reflect-
ing proliferation) was determined by
measuring the DNA content of cells
using a CyQUANT Cell Proliferation
Assay Kit (Life Technologies Hungary).
ORSKs (5,000 cells per well) were
cultured in 96-well black well plates
with clear bottom (Greiner Bio-One),
and were treated as indicated in octu-
plicates. Supernatants were then
removed by blotting on paper towels,
and the plates were subsequently
frozen at 80 C. The plates were then
thawed at room temperature, and 200
ml of CyQUANT dye/cell lysis buffer
mixture was added to each well. After 5
minutes of incubation, fluorescence
was measured at 490 nm excitation and
520 nm emission wavelengths using a
FlexStation II384 Multi-Mode Micro-
plate Reader (Molecular Devices).
Relative fluorescence values were
expressed as the percentage of the daily
vehicle control regarded as 100%.
Evaluation of cellular viability
To assess the effect on viability, we
applied an MTT assay (Sigma-Aldrich)
because mitochondrial enzymes of
living cells are able to transform
tetrazolium salt (MTT) into formazan
crystals. ORSKs were seeded in 96-well
plates (density: 10,000 cells/well) and
were treated as indicated in octupli-
cates with various concentrations of
CBD or vehicle. Cells were then incu-
bated with 0.5 mg/ml MTT reagent for 3
hours, and the concentration of for-
mazan crystals (as an indicator of
number of viable cells) was determined
colorimetrically at 565 nm by using a
FlexStation 3 Multi-Mode Microplate
Reader (Molecular Devices). Results
are expressed as percentage of vehicle
control regarded as 100%.
Determination of apoptosis
A decrease in the mitochondrial mem-
brane potential is one of the earliest
markers of apoptosis (Green and Reed,
1998; Susin et al., 1998). Therefore, to
assess the process, the mitochondrial
membrane potential of ORSKs was
determined using a MitoProbe DilC1(5)
Assay Kit (Life Technologies Hungary).
Cells (10,000 cells/well) were cultured
in 96-well black well plates with clear
bottom (Greiner Bio-One) in octupli-
cates and were treated as indicated.
After removal of supernatants, cells
were incubated for 30 minutes with
DilC1(5) working solution (50 ml/well),
then washed with PBS, and the fluo-
rescence of DilC1(5) was measured at
630 nm excitation and 670 nm emis-
sion wavelengths using a FlexStation
II384 Multi-Mode Microplate Reader
(Molecular Devices). Relative fluores-
cence values were expressed as the
percentage of vehicle control regarded
as 100%.
Determination of necrosis
Necrotic processes were determined by
SYTOX Green staining (Life Technolo-
gies Hungary). The dye is able to
penetrate (and then to bind to the
nucleic acids) only necrotic cells with
ruptured plasma membranes, whereas
healthy cells with intact surface mem-
branes show negligible SYTOX Green
staining intensity. Cells were cultured in
96-well black well plates with clear
bottom (Greiner Bio-One), and treated
as indicated. Supernatants were then
discarded, and the cells were incubated
for 30 minutes with 1 mM SYTOX Green
dye. Following incubation, cells were
washed with PBS, the culture medium
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was replaced, and fluorescence of
SYTOX Green was measured at 490 nm
excitation and 520 nm emission wave-
lengths using a FlexStation II384 Multi-
Mode Microplate Reader (Molecular
Devices). Relative fluorescence values
were expressed as the percentage of
negative control regarded as 100%.
Owing to their spectral properties,
DilC1(5) and SYTOX Green dyes were
always administered together, enabling
us to investigate necrotic and early
apoptotic processes of the same cul-
tures. Selective decrease of DilC1(5)
intensity indicated mitochondrial de-
polarization (i.e., the onset of early
apoptotic processes), whereas increase
of SYTOX Green staining intensity
revealed necrotic cell death.
Statistical analysis
When applicable, data were analyzed
using OriginPro Plus 6 software
(Microcal, Northampton, MA) using
chi-square test followed by Fisher’s
exact test, Student two-tailed unpaired
t-test, or analysis of variance with
Bonferroni post hoc test, and P < 0.05
values were regarded as significant
differences.
SUPPLEMENTARY DISCUSSION
Limitations of this Study
When interpreting the results presented
in the current exploratory, pilot study,
one has to keep in mind that, although
it sheds light on previously unknown
and potentially relevant (hair-wise)
dermatological effects of CBD, the
current work has certain important
limitations as well.
First and foremost, as mentioned in
the main text, our data need to be fol-
lowed up by systematic dose-response
experiments in a wider range of CBD
concentrations, tested in HF organ
cultures from additional patients to
explore the existence and magnitude of
inter-donor variability.
Second, in the current study, by
adding CBD (or vehicle) to the culture
medium we mimicked the effects of
systematically administered CBD.
However, from a translational point-of-
view it is crucially important to assess
the biological effects of CBD following
standardized topical application in
appropriate formulations.
Third, it is important to emphasize
that, in the current study, we used
microdissected, truncated HFs lacking
the bulge region as well as other (non-
HF) members of the pilosebaceous unit
(namely the sebaceous glands and the
arrector pili muscles). Therefore, we
cannot exclude the possibility that
specific (and most likely concentration
dependent) actions of CBD on these
structures may influence the production
and release of hair cycle-regulating
substances, further modifying its
already quite complex effects on the
hair cycle.
Fourth, studying microdissected HFs
ex vivo has the inherent limitation of
missing the effects and regulatory roles
of intact innervation and blood supply.
This may be crucially important,
because it can lead to model depen-
dently opposing observations in certain
cases. In the case of, for example, the
TRPV1-activating capsaicin, we have
previously shown that it suppressed
hair growth and induced premature
catagen entry in microdissected human
HFs (Bı´ro´ et al., 2006). Moreover, lack
of TRPV1 in knockout animals delayed
their normal hair cycle (Bodo´ et al.,
2005). However, administration of
capsaicin was found to promote hair
growth by increasing IGF-I production
in mice and in humans with alopecia,
most likely by acting on sensory nerve
fibers (Harada et al., 2007). Given the
broad target spectrum of CBD, one can
speculate that it may also modulate
production and release of hair cycle-
regulating substances from sensory
nerve endings. Therefore, its impact on
human hair biology may be even more
complex.
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Supplementary Figure S2. CBD decreases the ORSK cell count in a concentration- and time-dependent
manner. (a-d) CyQUANT assays. ORSKs were plated at low (5,000/well) initial cell count to enable rapid
proliferation. Cell count was assessed following (a) 3-, (b) 24-, (c) 48-, and (d) 72-hour treatments. Results
are expressed in the percentage of the daily vehicle control as mean  standard error of the mean of eight
independent determinations. Two additional experiments yielded similar results. ***P < 0.001 significant
difference compared with the respective control group. CBD, (e)-cannabidiol; ORSK, outer root sheath
keratinocyte.
Supplementary Figure S1. Macroscopic appearance of the HFs following the indicated CBD or vehicle
treatments (representative images). CBD, (e)-cannabidiol.
IL Szabo´ et al.
Cannabidiol Differentially Modulates Human Hair Growth
www.jidonline.org 488.e4
Supplementary Figure S3. High CBD concentrations reduce viability, and induce apoptosis-dominated
cell death. (a) ORSKs were treated as indicated for 24 hours, and viability and (b) cell death were
assessed by MTTassay and combined DilC1(5)-SYTOX Green labeling, respectively. Results are expressed
in the percentage of the vehicle control as mean  standard error of the mean of eight independent
determinations. Two additional experiments yielded similar results. ** P <0.01 or ***P < 0.001,
respectively, significant differences compared with the respective control group. CBD, (e)-cannabidiol;
DilC1(5), 1,1
0,3,3,30,30-hexamethylindodicarbo-cyanine iodide; ORSK, outer root sheath keratinocyte.
Supplementary Figure S4. Overview of the effects of CBD: CBD differentially influences human HF biology in a concentration-dependent manner. High
(10 mM) concentrations of CBD induced premature catagen entry by activating TRPV4 ion channels expressed on the ORSKs. Importantly, such a procatagen
effect of TRPV4 is not unprecedented, since it has recently been demonstrated that activation of this channel, similar to that of the structurally closely
related TRPV3 (Borbı´ro´ et al., 2011) and TRPV1 (Bı´ro´ et al., 2006; Bodo´ et al., 2005), is a potent inducer of catagen transformation of human HFs (Szabo´ et al.,
2019). Intriguingly, however, when applied at low, submicromolar concentrations, CBD tended to promote hair shaft production. Although, in light of the
unaltered proliferation and apoptosis rates, this may represent a pseudo-elongation of the hair shaft, which is pushed out of its anchorage in the HF by tissue
shrinkage during the course of organ culture, our data indicate that submicromolar concentrations of CBD may exert a differential effect on human HFs. Indeed,
0.1 mM CBD prevented the toll-like receptor 3 activator polyinosinic-polycytidylic acid-induced upregulation of several proinflammatory cytokines in cultured
ORSKs in an adenosine receptor-dependent manner, since the adenosine receptor pan-antagonist CGS 15943 (0.1 mM) could almost completely abrogate
this effect. Although exploration of the adenosine receptor expression profile of human HFs is beyond the scope of the current letter, these data suggest
that, besides the ones expressed on the dermal papilla cells (Iino et al., 2007), adenosine receptors of the ORSKs are also functionally active, and may contribute
to the regulation of hair cycle, as well as of other aspects of HF biology. Obviously, it remains to be investigated in future targeted studies if moderate hair
shaft production-promoting effects of low CBD concentrations are coupled to the A2B receptor-dependent upregulation of fibroblast growth factor-7 expression
in the dermal papilla (Iino et al., 2007), or are rather mediated in an ORSK-dependent manner, or that the two pathways complement each other. FGF7,
fibroblast growth factor-7; ORSK, outer root sheath keratinocyte.
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